LTRN Lantern Pharma Inc.

1d ago, source: Seeking Alpha

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its product pipeline ...

We're Not Very Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Rate

11d ago, source:

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

Will Lantern Pharma's AI-Driven Precision Oncology Strategy Pay Off?

2d ago, source: precisionmedicineonline

Clinical trial readouts later this year will provide the first indication of its RADR platform's potential to rescue drugs in biomarker-defined indications.

LP-184 by Lantern Pharma for Melanoma: Likelihood of Approval

4d ago, source: Pharmaceutical Technology

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Lantern Pharma advances cancer diagnostic tool

16d ago, source: Investing

DALLAS - Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company, announced significant progress in the development of a diagnostic tool for its cancer drug candidate LP-184. The ...

Lantern Pharma Inc. (LTRN)

16d ago, source: Yahoo Finance

DALLAS, July 10, 2024--Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence (AI) and machine learning to transform the cost, pace ...

Lantern Pharma Inc Ordinary Shares

10d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Lantern Pharma Inc Ordinary Shares LTRN

2d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Lantern Pharma, Inc.

4mon ago, source: CNN

Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184.

Lantern Pharma Inc.

29d ago, source: Wall Street Journal

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...